Get started
Author

Vasiliy Moroz

Observed names: V. D. Moroz, В.Д. Мороз
ORCID: 0009-0001-4588-8205
Observed ORCID: 0009-0001-4588-8205
OpenAlex ID: A5085373598
Development of Recombinant Oncolytic rVSV-mIL12-mGMCSF for Cancer Immunotherapy
2023 · Anastasia Ryapolova, Ekaterina Minskaia, et al. · International Journal of Molecular Sciences · 17
PDF
A Method for the Production of Recombinant VSVs with Confirmation of Biological Activity
2024 · V. D. Moroz, N. B. Gasanov, et al. · Acta Naturae · 10
Recombinant Oncolytic Vesicular Stomatitis Virus Expressing Mouse Interleukin-12 and Granulocyte-Macrophage Colony-Stimulating Factor (rVSV-dM51-mIL12-mGMCSF) for Immunotherapy of Lung Carcinoma
2025 · Anastasia Ryapolova, Margarita Zinovieva, et al. · International Journal of Molecular Sciences · 5
PDF
Recombinant VSVs: A Promising Tool for Virotherapy
2024 · K. A. Vorona, V. D. Moroz, et al. · Acta Naturae · 5
PDF
Inhibition of Chlamydial Infection by CRISPR/Cas9-SAM Mediated Enhancement of Human Peptidoglycan Recognition Proteins Gene Expression in HeLa Cells
2020 · P. A. Bobrovsky, V. D. Moroz, et al. · Biochemistry (Moscow) · 3
An Oncolytic Recombinant Vesicular Stomatitis Virus Expressing mGM-CSF and mIL-12 Enhances Antitumour Efficacy in a U-87 MG Glioblastoma Xenograft Model
2026 · Nizami B. Gasanov, Vasiliy Moroz, et al. · Cancers
PDF
Raw data for the manuscript:cancers-4432419 (resubmitted version of cancers-4320296)
2026 · Nizami B. Gasanov, Vasiliy Moroz, et al. · Zenodo (CERN European Organization for Nuclear Research)
Ингибирование хламидийной инфекции путем CRISPR/Cas9-SAM опосредованного усиления экспрессии генов пептидогликан-распознающих белков человека в клетках линии HeLa
2020 · П.А. Бобровский, В.Д. Мороз, et al. · Biochemistry (Moscow)
Works count: 9
Citation count: 40
H-index: 4
I10-index: 2
Year
Topic
Type